OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs
The recent introduction of novel β-lactam/β-lactamase inhibitor combinations like ceftazidime-avibactam has increased our ability to treat infections caused by multidrug-resistant Gram-negative bacteria, including carbapenemase-producing Enterobacterales. However, the increasing number of cases of r...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2019-03-01
|
Series: | mSphere |
Subjects: | |
Online Access: | https://doi.org/10.1128/mSphere.00024-19 |